TCT 312: Patent Foramen Ovale and Red Blood Cell Dysfunction: Quantifying Morphotype-Dependent Risk via Computational Fluid Dynamics

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Terumo Medical Corporation; Occlutech</li></ul>